# RISVAN
> **NDA214835** · New Drug Application · Sponsor: LABS FARMS ROVI SA · Approved 2024-03-29
## Drug
- **FDA Application Number:** NDA214835
- **Application type:** New Drug Application
- **Brand name:** RISVAN
- **Generic name:** Risperidone
- **Active ingredients:** RISPERIDONE
- **Dosage form:** FOR SUSPENSION, EXTENDED RELEASE
- **Route:** INTRAMUSCULAR
- **Marketing status:** Discontinued
- **Sponsor:** LABS FARMS ROVI SA
- **First approval:** 2024-03-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214835)
---
*MORVS · CC0 1.0*